Viagra effective Blue Pill - Erectile Dysfunction Treatment  Buy VIAGRA - Need to Buy VIAGRA ? Order Viagra Pills  Order VIAGRA | Need to Buy VIAGRA ? VIAGRA and LOVE !  Sexual Health & the presence of Viagra!   buy online viagra without prescription 1.15$ per PILL  Order VIAGRA - Need to Buy VIAGRA ? VIAGRA and LOVE $$$  Buying VIAGRA Pills - Need to Buy VIAGRA ? - Viagra Store $$$  Order VIAGRA - Need to Buy VIAGRA ? - Viagra Mall $$$  order generic viagra online without prescription 1.15$ per PILL  cheap viagra order online without prescription  Viagra: Get in the mood in a flash  Buy Viagra no prescription overnight, cheap viagra no prescription, real cheap viagra  Buying generic viagra online, viagra without prescription, viagra cheap overnight  Buy VIAGRA | Need to Buy VIAGRA ? | Turn To Rolling   Sex Life Gets Better With Viagra   Buy viagra without a prescription, viagra fedex overnight, overnight viagra  Buying VIAGRA Pills - Need to Buy VIAGRA ? - Viagra Mall $$  buy generic viagra buy cheap online uk viagra 1.15$ per PILL  Buying VIAGRA VIAGRA PIlls | Need to Buy VIAGRA ? | Cheap Prices  Viagra rivals add hours of hope for men   Viagra- A Sure Cure for Erectile Dysfunction (Impotence)   Get prescription online viagra, viagra overnight delivery, viagra without script  Order VIAGRA | Need to Buy VIAGRA ? Viagra Unlimited!  Purchase VIAGRA | Need to Buy VIAGRA ? | Viagra Store !

Buy Viagra Online, Click here!

Viagra is rapidly absorbed. Maximum observed plasma concentrations are reached within 30 to 120 minutes (median 60 minutes) of oral dosing in the fasted state. When Viagra is taken with a high fat meal, the rate of absorption is reduced, with a mean delay in Tmax of 60 minutes and a mean reduction in Cmax of 29%. The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues. Sildenafil and its major circulating N-desmethyl metabolite are both approximately 96% bound to plasma proteins. Protein binding is independent of total drug concentrations.
Men who are currently using medicines that contain nitrates, such as nitroglycerin should not use Viagra because taken together they can lower the blood pressure too much. Viagra should not be used by women or children.
Based upon measurements of sildenafil in semen of healthy volunteers 90 minutes after dosing, less than 0.001% of the administered dose may appear in the semen of patients.
Sildenafil is cleared predominantly by the CYP3A4 (major route) and CYP2C9 (minor route) hepatic microsomal isoenzymes. The major circulating metabolite results from N-desmethylation of sildenafil, and is itself further metabolized. This metabolite has a PDE selectivity profile similar to sildenafil and an in vitro potency for PDE5 approximately 50% of the parent drug. Plasma concentrations of this metabolite are approximately 40% of those seen for sildenafil, so that the metabolite accounts for about 20% of sildenafil's pharmacologic effects.

After either oral or intravenous administration, sildenafil is excreted as metabolites predominantly in the feces (approximately 80% of administered oral dose) and to a lesser extent in the urine (approximately 13% of the administered oral dose). Similar values for pharmacokinetic parameters were seen in normal volunteers and in the patient population, using a population pharmacokinetic approach.
Single oral doses of sildenafil (100 mg) administered to healthy volunteers produced decreases in supine blood pressure (mean maximum decrease in systolic/diastolic blood pressure of 8.4/5.5 mmHg). The decrease in blood pressure was most notable approximately 1–2 hours after dosing, and was not different than placebo at 8 hours. Similar effects on blood pressure were noted with 25 mg, 50 mg and 100 mg of Viagra, therefore the effects are not related to dose or plasma levels within this dosage range. Larger effects were recorded among patients receiving concomitant nitrates (see  CONTRAINDICATIONS).
At single oral doses of 100 mg and 200 mg, transient dose-related impairment of free viagara discrimination (blue/green) was detected using the Farnsworth-Munsell 100-hue test, with peak effects near the time of peak plasma levels. This finding is consistent with the inhibition of PDE6, which is involved in phototransduction in the retina. An evaluation of visual function at doses up to twice the maximum recommended dose revealed no effects of Viagra on visual acuity, intraocular pressure, or pupillometry.
In clinical studies, Viagra was assessed for its effect on the ability of men with erectile dysfunction (ED) to engage in sexual activity and in many cases specifically on the ability to achieve and maintain an erection sufficient for satisfactory sexual activity. Viagra was evaluated primarily at doses of 25 mg, 50 mg and 100 mg in 21 randomized, double-blind, placebo-controlled trials of up to 6 months in duration, using a variety of study designs (fixed dose, titration, parallel, crossover). Viagra was administered to more than 3,000 patients aged 19 to 87 years, with ED of various etiologies (organic, psychogenic, mixed) with a mean duration of 5 years. Viagra demonstrated statistically significant improvement compared to placebo in all 21 studies. The studies that established benefit demonstrated improvements in success rates for sexual intercourse compared with placebo.
Viagra® (sildenafil citrate) is a prescription medication used to treat erectile dysfunction, which is also known as impotence or ED. Viagra has been studied extensively in thousands of men with erectile dysfunction for various reasons. In all studies, Viagra has been shown to help men with erectile dysfunction engage in sexual activity.
The effectiveness of Viagra was evaluated in most studies using several assessment instruments. The primary measure in the principal studies was a sexual function questionnaire (the International Index of Erectile Function - IIEF) administered during a 4-week treatment-free run-in period, at baseline, at follow-up visits, and at the end of double-blind, placebo-controlled, at-home treatment. Two of the questions from the IIEF served as primary study endpoints; categorical responses were elicited to questions about (1) the ability to achieve erections sufficient for sexual intercourse and (2) the maintenance of erections after penetration. The patient addressed both questions at the final visit for the last 4 weeks of the study. The possible categorical responses to these questions were (0) no attempted intercourse, (1) never or almost never, (2) a few times, (3) sometimes, (4) most times, and (5) almost always or always. Also collected as part of the IIEF was information about other aspects of sexual function, including information on erectile function, orgasm, desire, satisfaction with intercourse, and overall sexual satisfaction. Sexual function data were also recorded by patients in a daily diary. In addition, patients were asked a global efficacy question and an optional partner questionnaire was administered.

add your comments